Anti-B cell agents: suppression of natural antibodies and prolongation of survival in discordant xenografts.
Blakely
M L
ML
Sandoz Center for Immunobiology, Harvard Medical School, Boston, Massachusetts.
Van der Werf
W J
WJ
Dalmasso
A P
AP
Bach
F H
FH
D000818:Animals; D000910:Antibodies, Heterophile / Q000096:biosynthesis* / Q000097:blood; D000917:Antibody Formation / Q000187:drug effects*; D001402:B-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D001713:Biphenyl Compounds / Q000494:pharmacology; D016572:Cyclosporine / Q000494:pharmacology; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006168:Guinea Pigs; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D011090:Polyenes / Q000494:pharmacology; D051381:Rats; D011917:Rats, Inbred Lew; D020123:Sirolimus; D013156:Splenectomy; D013997:Time Factors; D014183:Transplantation, Heterologous / Q000276:immunology*; D011798:Quinaldines
D000910:Antibodies, Heterophile; D001713:Biphenyl Compounds; D016572:Cyclosporine; D007166:Immunosuppressive Agents; D009173:Mycophenolic Acid; D011090:Polyenes; D020123:Sirolimus; C046943:brequinar; D011798:Quinaldines